bisoprolol has been researched along with albuterol in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.70) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 6 (26.09) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Baker, JG | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C | 1 |
| Chatterjee, SS | 1 |
| Lipworth, BJ; McDevitt, DG; McFarlane, LC; Wheeldon, NM | 1 |
| Lipworth, BJ; McDevitt, DG; Wheeldon, NM | 1 |
| Hall, JA | 1 |
| Allen, TW | 1 |
| Brown, MJ; Dickerson, JE; Ferro, A; Hall, JA | 1 |
| Emel'ianova, OI; Erokhina, IL; Okovityĭ, SV; Voronchikhin, PA | 1 |
| Bhushan, R; Malik, P | 1 |
| Benko, C; Bhatia, G; Cantor, M; Cluckers, L; Crumley, T; Heirman, I; Huang, Q; Izmailova, ES; Railkar, R; Rottey, S; Stoch, SA; Walters, C | 1 |
| Bennett, MR; Chang, CL; Hancox, RJ; Hopping, S; Tuffery, C | 1 |
2 review(s) available for bisoprolol and albuterol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for bisoprolol and albuterol
| Article | Year |
|---|---|
The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
Topics: Adrenergic beta-Antagonists; Aged; Albuterol; Asthma; Bisoprolol; Blood Pressure; Bronchial Provocation Tests; Female; Heart; Heart Rate; Humans; Hypertension; Hypotension; Male; Middle Aged; Organ Specificity; Propanolamines; Respiratory Function Tests; Time Factors | 1986 |
Beta-adrenoceptor subtypes mediating the metabolic effects of BRL 35135 in man.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Basal Metabolism; Bisoprolol; Blood Glucose; Fatty Acids, Nonesterified; Glycerol; Humans; Insulin; Lactates; Lactic Acid; Male; Nadolol; Phenethylamines; Potassium; Single-Blind Method | 1994 |
Cardiac effects of the beta 3-adrenoceptor agonist BRL35135 in man.
Topics: Administration, Oral; Adrenergic beta-Agonists; Adult; Albuterol; Bisoprolol; Drug Interactions; Hemodynamics; Humans; Male; Myocardial Contraction; Nadolol; Phenethylamines; Tremor | 1994 |
Beta adrenoreceptor subtype cross regulation in the human heart.
Topics: Adrenergic beta-Antagonists; Adult; Albuterol; Bisoprolol; Blood Pressure; Dose-Response Relationship, Drug; Drug Synergism; Exercise; Heart; Heart Rate; Humans; Male; Myocardium; Prospective Studies; Receptors, Adrenergic, beta; Stimulation, Chemical | 1993 |
"In-House" Data on the Outside-A Mobile Health Approach.
Topics: Adolescent; Adult; Aged; Albuterol; Antihypertensive Agents; Bisoprolol; Blood Pressure; Cross-Over Studies; Data Analysis; Heart Rate; Humans; Male; Middle Aged; Telemedicine; Young Adult | 2020 |
The impact of regular bisoprolol on the response to salbutamol in asthma: A double-blind randomized placebo-controlled crossover trial.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bisoprolol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Forced Expiratory Volume; Humans | 2021 |
15 other study(ies) available for bisoprolol and albuterol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2016 |
Cardiac beta 2-adrenoceptor stimulation in humans.
Topics: Adrenergic beta-Antagonists; Albuterol; Bisoprolol; Cardiotonic Agents; Humans; Myocardial Contraction; Receptors, Adrenergic, beta-2; Terbutaline | 1994 |
DOs encouraged to participate in pharmaceutical, clinical trials.
Topics: Albuterol; Antihypertensive Agents; Bisoprolol; Bronchodilator Agents; Clinical Trials, Phase III as Topic; Clinical Trials, Phase IV as Topic; Drug Combinations; Hydrochlorothiazide; Interdepartmental Relations; Osteopathic Medicine; Salmeterol Xinafoate | 1994 |
[Reaction of population of pulmonary mast cells in rat bronchial asthma under the effect of β-adrenoreceptor antagonists].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alcian Blue; Animals; Anti-Asthmatic Agents; Asthma; Bisoprolol; Budesonide; Cell Count; Disease Models, Animal; Drug Therapy, Combination; Glucocorticoids; Lung; Male; Mast Cells; Metoprolol; Phenazines; Rats; Receptors, Adrenergic, beta | 2013 |
Development of liquid chromatographic methods for enantioseparation and sensitive detection of β-adrenolytics/β2-agonists in human plasma using a single enantiomer reagent.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Antagonists; Albuterol; Bisoprolol; Carbazoles; Carvedilol; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Linear Models; Naproxen; Propanolamines; Reproducibility of Results; Stereoisomerism; Triazoles | 2017 |